Phase II study evaluating non-pegylated liposomal doxorubicin and dexamethasone in immunocompetent patients with refractory or relapsed brain lymphoma in first-line chemotherapy with high-dose methotrexate (MTXHD) and / or high-dose cytarabine.

Trial Profile

Phase II study evaluating non-pegylated liposomal doxorubicin and dexamethasone in immunocompetent patients with refractory or relapsed brain lymphoma in first-line chemotherapy with high-dose methotrexate (MTXHD) and / or high-dose cytarabine.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2013

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Dexamethasone
  • Indications B cell lymphoma
  • Focus Therapeutic Use
  • Acronyms MYLY
  • Most Recent Events

    • 11 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top